Hiramatsu, Katsutoshi
Hase, Masakazu
Ochi, Hirofumi
Funding for this research was provided by:
Biogen Japan Ltd. (NA)
Article History
Received: 6 September 2017
Accepted: 31 May 2018
First Online: 15 June 2018
Ethics approval and consent to participate
: Ethical approval was not obtained for this survey; however, ethical consideration was given to the participants. De-identified data were provided by M3, Inc. for the analysis, so that no individual responses were known to the authors. Consent to participate in the survey was obtained from all respondents.
: Consent to publication of survey results was obtained from all respondents.
: Katsutoshi Hiramatsu is an employee of Biogen Japan Ltd. and receives salaries from the company and possess the company’s stocks. Masakazu Hase was an employee of Biogen Japan Ltd., and received salaries from the company and possessed the company’s stocks at the time of this study conducted. Hirofumi Ochi has no conflict of interest with any company, organization or group to be disclosed in relation to this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.